Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173756 | SCV000224904 | benign | not specified | 2015-04-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000954642 | SCV001101287 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000173756 | SCV001476669 | benign | not specified | 2019-10-29 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002277339 | SCV002564878 | likely benign | Osteogenesis imperfecta | 2019-12-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002500460 | SCV002806585 | likely benign | Bone mineral density quantitative trait locus 1; Exudative vitreoretinopathy 4; Exudative vitreoretinopathy 1; Worth disease; Autosomal dominant osteopetrosis 1; Osteoporosis with pseudoglioma; Osteoporosis; Polycystic liver disease 4 with or without kidney cysts | 2021-08-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000954642 | SCV004137096 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | LRP5: BP4, BP7 |
Breakthrough Genomics, |
RCV000954642 | SCV005218844 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000173756 | SCV001978872 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000954642 | SCV001980614 | likely benign | not provided | no assertion criteria provided | clinical testing |